Form 4 for ACAD ACADIA PHARMACEUTICALS INC
Accepted 2022-01-10 00:00:00 ET · period of report 2022-01-06 · accession 0001209191-22-002749 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-10 | 2022-01-06 | ACAD | Stankovic Srdjan R. | Pres | S - Sale+OE | $23.05 | -1,937 | 45.0K | -4% | -$44.6K |
| D | 2022-01-10 | 2022-01-06 | ACAD | Stankovic Srdjan R. | Pres | M - OptEx | — | +5,444 | 47.0K | +13% | — |
| D | 2022-01-10 | 2022-01-06 | ACAD | Stankovic Srdjan R. | Pres | M - OptEx | $0.00 | -5,444 | 10.9K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-06 | S | D | 1,937 | $23.05 | 45,019 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-06 | M | A | 5,444 | — | 46,956 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 3 | Derivative | Restricted Stock Units | 2022-01-06 | M | D | 5,444 | $0.00 | 10,889 | D | — · — to — | 5,444 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F3) The restricted stock units vest in four equal annual installments beginning January 6, 2021. |